| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $11,054,020 ) (Continued on the next page) |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R13DC019564 | International Conference on Advances in Quantitative Laryngology,Voice and Speech Research (AQL) | 000 | 4 | NIH | 1/10/2024 | $2,000 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL133501 | Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure | 000 | 6 | NIH | 11/8/2023 | $580,262 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI128729 | Mechanisms of IL-33 secretion in allergic diseases | 000 | 8 | NIH | 1/29/2024 | $544,098 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK092460 | Fat in Pancreatitis - a Focus on Hypertriglyceridemic Pancreatitis | 000 | 14 | NIH | 12/12/2023 | $430,867 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AA031257 | Biomarkers and pathogenesis of Alcoholic acute pancreatitis | 000 | 1 | NIH | 2/29/2024 | $608,856 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL172784 | Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium | 000 | 1 | NIH | 3/29/2024 | $688,146 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL167811 | Opportunistic Screening for ASCVD using a Multimodal Deep Learning Risk Prediction Model | 000 | 1 | NIH | 12/11/2023 | $698,520 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA271431 | STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22 | 001 | 2 | NIH | 4/18/2024 | $29,777 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA271431 | STAT5/OLIG2 regulation of GBM therapeutic resistance and recurrence - Resubmit 3.22 | 000 | 2 | NIH | 1/29/2024 | $535,979 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI176254 | Tools for reversible short-term degradation of TCF-1 to address its molecular functions | 000 | 2 | NIH | 2/23/2024 | $186,750 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R13DC021115 | Society of Ears, Nose, and Throat Advances in Children (SENTAC) | 000 | 2 | NIH | 3/6/2024 | $40,000 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R21AI175813 | Delineating mechanisms underlying the enhanced stability and functionality of CD2- KO Tregs and chimeric antigen receptor (CAR) Tregs and their application in xenotransplantation | 000 | 3 | NIH | 12/6/2023 | $187,314 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 004 | 2 | NIH | 1/18/2024 | $291,041 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 002 | 2 | NIH | 1/9/2024 | $0 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL161674 | Gender and Asthma | 001 | 2 | NIH | 12/18/2023 | $373,856 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL162747 | Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | 000 | 2 | NIH | 1/4/2024 | $652,089 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01GM141003 | Impact of membrane composition on cholecystokinin receptor structure and function | 000 | 3 | NIH | 11/10/2023 | $415,470 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 001 | 4 | NIH | 4/18/2024 | $17,221 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA238926 | HRD-IA signatures in pancreatic ductal adenocarcinoma | 000 | 4 | NIH | 1/30/2024 | $308,488 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK132651 | Role of SIRT7 in the Pancreatic Beta Cells | 000 | 3 | NIH | 3/20/2024 | $372,706 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK130566 | Healing enterocutaneous fistulas using bioengineered biomaterials | 000 | 3 | NIH | 11/9/2023 | $513,592 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA257558 | Drug eluting injectable biomaterials for next generation chemoembolization | 000 | 4 | NIH | 4/5/2024 | $587,009 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 003 | 4 | NIH | 4/18/2024 | $5,025 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 002 | 4 | NIH | 4/18/2024 | $33,356 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 000 | 4 | NIH | 3/4/2024 | $600,426 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA250481 | Image-based models of tumor-immune dynamics in glioblastoma | 001 | 4 | NIH | 3/6/2024 | $90,449 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37AI071106 | Mechanisms of Allergen-induced Type 2 Immunity | 000 | 18 | NIH | 4/15/2024 | $578,847 |
| | 2024 | 2024 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI147652 | Molecular functions of Tcf-1 in DP thymocytes | 000 | 6 | NIH | 10/26/2023 | $373,500 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK125680 | A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms | 000 | 3 | NIH | 10/19/2023 | $0 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | P50CA186781 | Mayo Clinic Multiple Myeloma SPORE | 000 | 8 | NIH | 1/22/2024 | $0 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01DK073983 | Advancing Science for the Diagnosis and Treatment of Gastroparesis | 001 | 17 | NIH | 11/7/2023 | $459,189 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U54CA274504 | Mathematical Oncology Systems Analysis Imaging Center (MOSAIC) | 000 | 1 | NIH | 10/18/2023 | $0 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R33NS113315 | Biomarker Signature to Predict the Persistence of Post-Traumatic Headache | 000 | 2 | NIH | 3/6/2024 | $675,765 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA272426 | preclinical optimization of BCMA directed T cell therapy | 000 | 1 | NIH | 12/20/2023 | $0 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K23AG073525 | Neurodegeneration and Neuronal Fluctuations in DLB and AD | 001 | 3 | NIH | 11/3/2023 | $145,711 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01CA264048 | Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen | 000 | 3 | NIH | 12/11/2023 | $0 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK125680 | A randomized control trial of G-POEM for gastroparesis to assess feasibility, safety, efficacy and physiological mechanisms | 003 | 3 | NIH | 2/20/2024 | $596,104 |
| | 2024 | 2023 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | K01CA230193 | Genetic Literacy and Patient-Caregiver Communication of Prognostic Genetic Technology for Localized Prostate Cancer | 000 | 4 | NIH | 12/6/2023 | $0 |
| | 2024 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37CA252060 | Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training | 001 | 3 | NIH | 2/15/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01DK119646 | Pathogenesis of infection in pancreatitis: from sterile inflammation to sepsis | 000 | 4 | NIH | 10/18/2023 | $0 |
| | 2024 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | P01CA229100 | Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma | 000 | 5 | NIH | 3/29/2024 | $0 |
| | 2024 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01AI108682 | How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal | 000 | 8 | NIH | 2/6/2024 | $241,699 |
| | 2024 | 2022 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R37CA252060 | Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training | 000 | 3 | NIH | 10/23/2023 | $0 |
| | 2024 | 2021 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | UH3CA217847 | Development of Mantle Cell Lymphoma Proliferation Signature Assay | 000 | 5 | NIH | 3/4/2024 | -$1 |
| | 2024 | 2021 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | R01HL140951 | Treatment of arterial aneurysms using an injectable biomaterial | 000 | 4 | NIH | 1/29/2024 | -$5,300 |
| | 2024 | 2021 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA220378 | Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma | 002 | 5 | NIH | 1/31/2024 | -$7,652 |
| | 2024 | 2021 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA220378 | Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma | 001 | 5 | NIH | 1/31/2024 | -$17,180 |
| | 2024 | 2021 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U01CA220378 | Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma | 000 | 5 | NIH | 1/31/2024 | -$69,094 |
| | 2024 | 2021 | MAYO CLINIC ARIZONA | 13400 E SHEA BLVD | SCOTTSDALE | AZ | 85259-5452 | MARICOPA | USA | U54CA224018 | Overcoming Drug Resistance in Multiple Myeloma | 001 | 4 | NIH | 2/6/2024 | -$2,459 |
|
